بروتين المرحلة الحادة للإلتهاب (CRP) كمنبئ للوفيات القلبية الوعائية عند مرضى التحال الدموي

Authors

  • عنان لايقة

Abstract

objective: to establish and examined associations of C-reactive protein (CRP) levels that would predict increased overall and cardiovascular mortality in patients with end-stage renal disease

. Methods. A cohort of 58 prevalent hemodialysis patients treated at teshreen University Hospital, was eligible for the study. CRP, albumin , creatinin ,urea and hemoglobin , measurements were performed for two consecutive months.

. During the one-year follow-up, 12 patients died The most frequent cause of death was cardiovascular. CRP baseline concentration correlates well( 85%) with mortality in patients with ESRD .

In conclusion, the current study findings suggest that CRP as a prototypical acute phase protein in humans is a strong predictor of overall and cardiovascular mortality

in patients with ESRD.

إن هدف هذه الدراسة هو تقييم و فحص العلاقة ما بين ارتفاع  (  CRP ) المصل و التنبؤ بالوفيات القلبية الوعائية عند مرضى التحال الدموي.

58 مريضا موضوعين على التحال الدموي في مشفى تشرين الجامعي , حيث تم معايرة (CRP )المصل , الألبومين, كرياتينين المصل , البولة الدموية , و خضاب الدم .

و تمت متابعتهم لمدة عام كامل , من حيت الوفيات و الحوادث القلبية الوعائية .

النتائج أظهرت : 12 مريضا توفوا ,  و أن 85% من المرضى الذين توفوا كان لديهم ارتفاع في مستوى  CRP المصل , و أن الحوادث القلبية الوعائية هي من أكثر أسباب الوفيات حدوثا.

إن نتائج هذه الدراسة تظهر أن ارتفاع بروتينات المرحلة الحادة للإلتهاب CRP, هو منبئ قوي للوفيات القلبية الوعائية عند مرضى القصور الكلوي النهائي .

Downloads

Published

2018-10-15

How to Cite

1.
لايقة ع. بروتين المرحلة الحادة للإلتهاب (CRP) كمنبئ للوفيات القلبية الوعائية عند مرضى التحال الدموي. Tuj-hlth [Internet]. 2018Oct.15 [cited 2024Apr.18];39(6). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/4165

Issue

Vol. 39 No. 6 (2017): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)